Sichuan Huiyang Life Engineering

Sichuan Huiyang Life Engineering is a Chinese biotechnology company focused on the research, development, and commercialization of innovative anti-cancer therapies derived from natural sources. The company's lead candidate, HY-1 (also known as Huiyang-1), is a proprietary small molecule compound extracted and purified from botanical sources, designed to inhibit tumor growth by targeting DNA replication and repair mechanisms. Sichuan Huiyang operates primarily out of Chengdu and has conducted multiple clinical trials in China targeting various solid tumors, including hepatocellular carcinoma and lung cancer. The company aims to provide low-toxicity, high-efficacy alternatives to traditional chemotherapy through its focus on natural product chemistry and modern pharmacological validation.